ASO Perspectives: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer: Never Stop Questioning

被引:0
|
作者
Bryan J. Schneider
Andrew C. Chang
机构
[1] University of Michigan,Department of Internal Medicine
[2] University of Michigan,Department of Surgery
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
This ASO perspective reviews the findings of a randomized placebo-controlled, clinical trial evaluating adjuvant nivolumab in esophageal or gastroesophageal junction carcinoma, reported recently by the Checkmate 577 investigators. The use of postoperative immunotherapy represents a significant paradigm shift for managing patients who have had limited evidence-based treatment options after completing neoadjuvant chemoradiation followed by resection for these aggressive malignancies.
引用
下载
收藏
页码:2735 / 2738
页数:3
相关论文
共 50 条
  • [31] Adjuvant nivolumab after neoadjuvant chemoradiotherapy and surgery for patients with esophageal or gastroesophageal junction cancer: A nationwide real-world matched comparison of overall survival
    Verhoeven, R. H. A.
    Kuijper, S. C.
    Slingerland, M.
    Wijnhoven, B. P. L.
    Henegouwen, M. I. van Berge
    van Rossum, P. S. N.
    Derks, S.
    Mostert, B.
    Mohammad, N. Haj
    van Laarhoven, H. W. M.
    ANNALS OF ONCOLOGY, 2024, 35 : S176 - S177
  • [32] A multicountry chart review of treatment patterns and outcomes for patients with resected esophageal or gastroesophageal junction cancer.
    Singh, Prianka
    Gricar, Joseph
    Mackie, deMauri S.
    Xiao Hong
    DeCongelio, Marc
    Jaffe, Dena H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [33] Induction nivolumab or nivolumab/ipilimumab prior to concurrent chemoradiation plus nivolumab in patients with operable stage II/III esophageal/gastroesophageal junction cancer.
    Kelly, Ronan Joseph
    Hales, Russell K.
    Battafarano, Richard James
    Voong, K. Ranh
    Yang, Stephen C.
    Shin, Eun Ji
    Hu, Chen
    Anagnostou, Valsamo
    Velculescu, Victor E.
    Feliciano, Josephine Louella
    Thompson, Elizabeth
    Smith, Kellie Nicole
    Sears, Cynthia
    Pardoll, Drew M.
    Rowe, Valerie
    Rodavia, Hanika
    Amjad, Ali Imran
    Guerrieri, Patrizia
    Jobe, Blair Anderson
    Zaidi, Ali Hussainy
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] Adjuvant Nivolumab in Esophageal Cancer - A New Standard of Care
    Ilson, David H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13): : 1269 - 1271
  • [35] Neo-adjuvant radiochemotherapy for gastroesophageal junction cancer
    Sole Z, Sebastian
    Carvajal C, Claudia
    REVISTA CHILENA DE CIRUGIA, 2013, 65 (02): : 192 - 194
  • [37] A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectives
    Chiappa, Antonio
    Andreoni, Bruno
    Dionigi, Renzo
    Spaggiari, Lorenzo
    Foschi, Diego
    Polvani, Gianluca
    Orecchia, Roberto
    Fazio, Nicola
    Pravettoni, Gabriella
    Cossu, Maria Laura
    Galetta, Domenico
    Venturino, Marco
    Ferrari, Carlo
    Macone, Lorenzo
    Crosta, Cristiano
    Bonanni, Bernardo
    Biffi, Roberto
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 132 : 161 - 168
  • [38] Comparison of adjuvant chemoradiation to perioperative chemotherapy for the treatment of resected gastric and gastroesophageal junction adenocarincoma
    Lim, Howard John
    Kim, Hae Rin
    Schellenberg, Devin
    Kollmannsberger, Christian K.
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [39] Quality criteria for esophageal and gastroesophageal junction cancer surgery
    Mariette, C.
    Robb, W. B.
    Piessen, G.
    ONCOLOGIE, 2013, 15 (3-4) : 133 - 138
  • [40] Design and rationale of the PROSPECTive evaluation of nivolumab in adjuvant esophageal cancer/gastroesophageal junction cancer (EC/GEJC) (PROSPECT-ESO): A prospective, non-interventional, multicentre cohort study
    Shah, M. A.
    Saeed, A.
    Kakehi, S.
    Kelly, R. J.
    Kondo, K.
    Herber, M.
    Stein, A.
    Khan, Z.
    Sestak, I.
    Halchenko, Y.
    Davis, C.
    Singh, P.
    ANNALS OF ONCOLOGY, 2024, 35 : S200 - S200